Drug Patents owned by Mitsubishi Holdings

1. List of Exservan drug patents

EXSERVAN's oppositions filed in EPO
EXSERVAN Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765167 MITSUBISHI HOLDINGS Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Feb, 2024

(10 months from now)

US8603514 MITSUBISHI HOLDINGS Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Apr, 2024

(1 year, 7 days from now)

Drugs and Companies using RILUZOLE ingredient

Market Authorisation Date: 22 November, 2019

Treatment: NA

Dosage: FILM;ORAL

More Information on Dosage

EXSERVAN family patents

117

United States

25

European Union

24

Japan

21

Australia

17

Canada

14

China

5

Denmark

3

Austria

3

Spain

3

Korea, Republic of

2

Mexico

2

Brazil

1

Israel

1

South Africa

1

Ireland

1

Russia

1

Norway

1

Argentina

1

Malaysia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in